Literature DB >> 1853161

Viral haemorrhagic fever in Sweden: experiences from management of a case.

U Foberg1, A Frydén, B Isaksson, P Jahrling, A Johnson, K McKee, B Niklasson, B Normann, C Peters, M Bengtsson.   

Abstract

The first recognized case in Scandinavia with potential man to man transmission of viral haemorrhagic fever occurred in Linköping, Sweden, in January 1990. Following a visit to Kenya a 21-year-old male student suffered a very severe illness including extremely prolonged high grade fever, rash, disseminated intravascular coagulation with thrombocytopenia and severe bleedings. This necessitated one month of intensive care support including respirator treatment. The patient was discharged after 2 1/2 months in good condition, with a partial femoral nerve paresis. About 100 medical personnel were exposed to aerosol or blood before a strict containment regimen was established. No secondary cases occurred.

Entities:  

Mesh:

Year:  1991        PMID: 1853161     DOI: 10.3109/00365549109023392

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  3 in total

Review 1.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

2.  Retrospective meta-transcriptomic identification of severe dengue in a traveller returning from Africa to Sweden, 1990.

Authors:  Kristian Alfsnes; Nina Lagerqvist; Sirkka Vene; Jon Bohlin; Jenny Verner-Carlsson; David Ekqvist; Andreas Bråve; Edward C Holmes; Weifeng Shi; John H-O Pettersson
Journal:  One Health       Date:  2021-01-22

Review 3.  Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review.

Authors:  Mona Hersi; Adrienne Stevens; Pauline Quach; Candyce Hamel; Kednapa Thavorn; Chantelle Garritty; Becky Skidmore; Constanza Vallenas; Susan L Norris; Matthias Egger; Sergey Eremin; Mauricio Ferri; Nahoko Shindo; David Moher
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.